Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction by Mauro Gori, James L Januzzi, Emilia D’Elia, Ferdinando L Lorini, Michele Senni

Get full text

Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial by Thomas H. Marwick, Carolyn Lam, Yuxi Liu, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, W. H. Wilson Tang, Faiez Zannad, Riccardo Perfetti, James L. Januzzi

Get full text

Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus by Nasrien Ibrahim, Renata Mukai, Craig Magaret, Rhonda Rhyne, Grady Barnes, Roland R J van Kimmenade, James L Januzzi, Cian P McCarthy, Shreya Shrestha, Hanna K Gaggin, Joseph M Garasic

Get full text

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) stu... by James L Januzzi, Hanna K Gaggin, Megan Welch, Daniel A Zlotoff, Kevin Wei, Andrew Abboud, Austin Nguonly, Asher Bean, Kemar J Brown, Roy F Chen, David Dudzinski, Neyat Fiseha, Melvin Joice, Davis Kimaiyo, Mackenzie Martin, Christy Taylor

Get full text